What is the recommended dosage of N-acetylcysteine (NAC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

N-Acetylcysteine Dosing for Acetaminophen Overdose

For acetaminophen overdose, administer N-acetylcysteine (NAC) using either the oral regimen (140 mg/kg loading dose followed by 70 mg/kg every 4 hours for 17 doses over 72 hours) or the intravenous regimen (150 mg/kg over 15 minutes, then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours), with the choice based on clinical presentation and patient tolerance. 1, 2

Standard Dosing Regimens

Oral NAC Protocol

  • Loading dose: 140 mg/kg orally or via nasogastric tube, diluted to 5% solution 1, 2
  • Maintenance doses: 70 mg/kg every 4 hours for 17 additional doses (total 72 hours) 1, 3
  • This 72-hour oral regimen is as effective as the 20-hour IV regimen and may be superior when treatment is delayed 3

Intravenous NAC Protocol

  • Loading dose: 150 mg/kg in 5% dextrose over 15 minutes 1, 2
  • Second dose: 50 mg/kg over 4 hours 1, 2
  • Third dose: 100 mg/kg over 16 hours (total 21-hour protocol) 1, 2

Timing-Based Treatment Algorithm

Early Presentation (0-8 hours post-ingestion)

  • Start NAC immediately if acetaminophen level plots above the treatment line on the Rumack-Matthew nomogram 2
  • Treatment within 8 hours results in only 2.9% developing severe hepatotoxicity 4, 5
  • No difference in outcome whether NAC is started 0-4 hours versus 4-8 hours after ingestion 3

Intermediate Presentation (8-24 hours post-ingestion)

  • Efficacy decreases progressively: 6.1% severe hepatotoxicity when treated within 10 hours, 26.4% when treated 10-24 hours 4, 3
  • Among high-risk patients treated 16-24 hours after ingestion, 41% develop hepatotoxicity—still lower than untreated controls (58%) 2, 3
  • NAC remains indicated and beneficial throughout this window 3

Late Presentation (>24 hours post-ingestion)

  • The Rumack-Matthew nomogram does NOT apply beyond 24 hours 2
  • Administer NAC immediately based on acetaminophen levels, liver function tests, and clinical presentation rather than nomogram placement 2
  • NAC still provides benefit in reducing hepatotoxicity and mortality even with delayed treatment 2

Special Clinical Scenarios Requiring Modified Dosing

Massive Overdose (Very High Acetaminophen Levels)

  • For acetaminophen concentrations above the "300-line" on the nomogram, consider step-wise increases in NAC dosing 6
  • Further dose increases may be warranted at the 450-line and 600-line 6
  • This represents an emerging area where standard dosing may be insufficient 6

Established Hepatic Failure

  • Administer IV NAC regardless of time since ingestion (Level B recommendation) 1, 2
  • NAC reduces mortality from 80% to 52%, cerebral edema from 68% to 40%, and need for inotropic support from 80% to 48% 2
  • Continue NAC until transaminases are declining and INR normalizes 2

Extended-Release Acetaminophen

  • Use standard dosing regimen, but monitoring may need to be extended 1
  • Absorption is prolonged, requiring longer observation and potentially extended NAC therapy 1

Repeated Supratherapeutic Ingestions

  • Standard 72-hour oral protocol commonly applied 1
  • Treat if ≥10 g or 200 mg/kg (whichever is less) during a single 24-hour period 2
  • Treat if ≥6 g or 150 mg/kg (whichever is less) per 24-hour period for ≥48 hours 2

High-Risk Populations (Chronic Alcohol Use, Fasting, Liver Disease)

  • Treat even if acetaminophen levels are below typical treatment threshold 1, 2
  • These patients may develop toxicity at lower doses 1
  • Consider lower threshold for extended treatment 2

Duration of Treatment Considerations

Standard Duration

  • Complete the full 72-hour oral protocol or 21-hour IV protocol for most patients 1, 3

Criteria for Early Discontinuation (Carefully Selected Cases Only)

  • Acetaminophen level is undetectable AND liver function tests remain completely normal 2
  • Any elevation in AST or ALT above normal mandates continuing NAC 2
  • If criteria are met at 12 hours, a shortened course may be safe in low-risk patients, but this requires careful consideration 2

Mandatory Extended Treatment Beyond Standard Protocol

  • Delayed presentation (>24 hours post-ingestion) 2
  • Extended-release acetaminophen formulations 2
  • Repeated supratherapeutic ingestions 2
  • Unknown time of ingestion with detectable acetaminophen levels 2
  • Any elevation in AST or ALT above normal 2
  • Chronic alcohol use 2

Critical Red Flags Requiring Immediate NAC Restart

  • Any elevation in AST or ALT above normal 2
  • Rising transaminases 2
  • Any coagulopathy 2
  • Detectable acetaminophen level 2
  • Clinical signs of hepatotoxicity 2

Important Clinical Pitfalls

Do Not Delay NAC for These Reasons:

  • Do not wait for confirmatory acetaminophen levels if there is strong suspicion of significant overdose 1
  • Do not delay NAC even if activated charcoal has been given 1
  • Activated charcoal (1 g/kg) may be given just prior to starting NAC if patient presents within 4 hours, but NAC should not be delayed 1, 2

Common Dosing Errors to Avoid:

  • The FDA-labeled 3-step IV regimen is complex and produces frequent medication errors 7
  • Loading dose errors are most common, particularly rate-related and dose-related errors 7
  • Ensure proper dilution and infusion rates to minimize adverse effects 7

When Low or Absent Acetaminophen Levels Are Misleading:

  • Low or absent levels do NOT rule out acetaminophen poisoning if ingestion was remote or occurred over several days 2, 5
  • Very high aminotransferases (AST/ALT >3,500 IU/L) are highly correlated with acetaminophen poisoning and should prompt NAC treatment even without clear history 2, 5

Comparison of Oral vs. Intravenous Routes

  • The 72-hour oral regimen is as effective as the 20-hour IV regimen 3
  • Oral NAC may be superior when treatment is delayed 3
  • IV route preferred when: oral route not tolerated, patient cannot protect airway, fulminant hepatic failure present, or rapid treatment initiation needed 1
  • Oral route offers increased tolerability and reduced hospital stay in appropriate patients 8

References

Guideline

N-Acetylcysteine Administration in Acetaminophen Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acetaminophen Toxicity Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended dose of N-acetyl cysteine (NAC)?
What is the oral dose of acetylcysteine (N-acetylcysteine) for acetaminophen (paracetamol) overdose and as a mucolytic agent?
What is the recommended dosage and regimen for N-acetylcysteine (NAC) treatment?
What is the recommended dose of N-acetyl cysteine (NAC)?
What is the recommended dosage of N-acetylcysteine (NAC) for acetaminophen overdose?
What is the dosage and usage of N-acetylcysteine (NAC) in clinical scenarios?
What is the optimal management plan for a patient with acute upper GI bleeding secondary to high-grade esophageal and gastric varices, likely due to underlying portal hypertension, who has been stabilized with blood transfusion and definitive acute management via endoscopic variceal ligation and glue injection?
What is the difference in timeline between Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD)?
What is the diagnosis and treatment for a patient with a swollen distended abdomen (abdominal distension) with tight skin and no visible subcutaneous fat, suggestive of ascites?
What is the appropriate management plan for a patient with advanced chronic kidney disease, presenting with symptoms such as generalized swelling, vomiting, dizziness, fatigue, shortness of breath, decreased urine output, and back pain, with laboratory results showing impaired renal function, hyperkalemia, hyponatremia, hypocalcemia, and significant proteinuria?
What are the potential interactions between nattokinase and anticoagulant or antiplatelet medications, such as warfarin (warfarin), aspirin (acetylsalicylic acid), or clopidogrel (clopidogrel)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.